Ohcanbohtosat - David Workman

Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial Dahkki Guy de Bruyn, Jamshid Saleh, David Workman, Richard Pollak, Victor Elinoff, Neil J. Fraser, Gigi Lefebvre, Mark G. Martens, Richard Mills, Richard Nathan, Miguel Á. Treviño, Martin van Cleeff, Ginamarie Foglia, Ayca Ozol-Godfrey, Dhaval M. Patel, Patricia J. Freda Pietrobon, Richard Gesser